Irritable bowel syndrome (IBS) is the most common functional gastrointestinal disorder, affecting 10–15% of the global population and accounting for 25–50% of gastroenterology referrals. It is defined by the Rome IV criteria (2016): recurrent abdominal pain averaging at least 1 day per week over the past 3 months, associated with 2 or more of: (1) related to defecation, (2) associated with a change in stool frequency, (3) associated with a change in stool form (appearance). Critically, IBS is a diagnosis of exclusion requiring absence of structural, inflammatory, or biochemical abnormalities that would explain the symptoms.
The core mechanism of IBS is visceral hypersensitivity — the gut is not objectively more diseased or damaged in most IBS patients, but the brain-gut signaling is dysregulated such that normal gut sensations (gas, distension, peristalsis) are perceived as painful. This is not psychological fabrication — neuroimaging studies show altered central pain processing, and gut-specific mast cell activation and serotonin dysregulation provide a peripheral component. Understanding IBS as a brain-gut disorder — rather than a gut disease — is why treatments targeting the gut alone have limited success, and why gut-directed psychotherapy (hypnotherapy, CBT) has some of the strongest evidence of any IBS intervention.
| Subtype | Primary Mechanism | First-Line | Second-Line | Prescription Options |
|---|---|---|---|---|
| IBS-D (diarrhea predominant) | High gut serotonin, rapid transit, visceral hypersensitivity; often post-infectious | Low-FODMAP elimination; soluble fiber (psyllium); peppermint oil enteric-coated | Rifaximin 14-day course; gut-directed hypnotherapy/CBT; low-dose tricyclic antidepressant (amitriptyline 10–25mg) | Alosetron (5-HT3 antagonist — women with severe IBS-D); eluxadoline (μ-opioid agonist) |
| IBS-C (constipation predominant) | Low gut serotonin, slow transit; visceral hypersensitivity | Soluble fiber (psyllium 10–20g/day); increased hydration; movement/exercise; magnesium citrate | Low-FODMAP (modified — sorbitol/polyols restriction); gut-directed therapy; low-dose SNRI (duloxetine) | Linaclotide (guanylate cyclase-C agonist); plecanatide; lubiprostone (chloride channel activator); prucalopride (5-HT4 agonist) |
| IBS-M (mixed) / IBS-U (unsubtyped) | Variable transit; alternating constipation and diarrhea; often highest anxiety comorbidity | Low-FODMAP; gut-directed hypnotherapy; stress management; regular meals and sleep schedule | Low-dose tricyclic antidepressant (modulates gut motility bidirectionally); CBT | Antispasmodics (dicyclomine, hyoscyamine) for acute cramping episodes |
Phase 1 — Strict elimination (4–6 weeks): Remove ALL high-FODMAP foods simultaneously; common high-FODMAP culprits: wheat and rye (bread, pasta, crackers), onion and garlic (in virtually all processed foods and restaurant food — the most commonly missed source), apples and pears, stone fruits (peaches, plums, cherries, apricots), most legumes (chickpeas, lentils, black beans — small servings of canned/rinsed may be tolerated), most dairy with lactose, honey and high-fructose corn syrup, cashews and pistachios, cauliflower and mushrooms; safe foods: rice, oats, potatoes, most proteins (meat, fish, eggs, tofu), most vegetables (carrots, spinach, zucchini, eggplant, tomatoes), lactose-free dairy, hard cheeses, strawberries, blueberries, citrus.
Phase 2 — Structured reintroduction (6–8 weeks): Test one FODMAP category at a time, in 3-day cycles; example — test fructans (onion): day 1 small serving, day 2 larger serving, day 3 normal serving; days 4–5: washout period; assess symptoms on each day; if tolerated, this FODMAP type is likely safe in normal amounts; move to next category; categories to test: fructans (onion/garlic separately — most people react to garlic more than onion), lactose, excess fructose (apples/honey), GOS (legumes), polyols (sorbitol in stone fruits vs. mannitol in mushrooms separately); the goal is to identify WHICH FODMAPs trigger symptoms, not to stay on strict low-FODMAP permanently.
Phase 3 — Personalized long-term diet: Return all tolerated foods; restrict only the specific FODMAP categories that triggered symptoms; most IBS patients tolerate 2–4 FODMAP categories normally and are sensitive to only 1–2; a personalized diet is far less restrictive than permanent strict low-FODMAP AND maintains better microbiome diversity (low-FODMAP chronically reduces Bifidobacterium, which is counterproductive for long-term gut health); common pattern: garlic and onion are the universal triggers; most people can tolerate legumes in small servings if rinsed, and most stone fruits if limited.
Peppermint oil enteric-coated: Merat 2010 (Digestive Diseases and Sciences, meta-analysis): enteric-coated peppermint oil capsules significantly reduced IBS symptom severity; menthol (peppermint's primary compound) is a calcium channel antagonist in smooth muscle → antispasmodic effect; reduces cramping and urgency; enteric-coated is mandatory (uncoated causes GERD/heartburn as it relaxes the lower esophageal sphincter before reaching the colon); dose: 0.2–0.4ml enteric-coated, 2–3× daily before meals; IBgard is the commonly available branded formulation; one of the most evidence-supported OTC options for IBS-D.
As an Amazon Associate, GutCode earns from qualifying purchases made through links on this page. This does not affect the price you pay.